INOVIO PHARMACEUTICALS, INC. Debt Securities, Available-for-sale, Realized Gain
INOVIO PHARMACEUTICALS, INC. (INO) reported Debt Securities, Available-for-sale, Realized Gain of $200 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGain · last filed 2026-08-12
- INOVIO PHARMACEUTICALS, INC. debt securities, available-for-sale, realized gain for the quarter ending 2026-06-30 was $200.00, a 33.33% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. debt securities, available-for-sale, realized gain for the quarter ending 2026-03-31 was $200.00, a 0.00% change year-over-year.
- INOVIO PHARMACEUTICALS, INC. debt securities, available-for-sale, realized gain for the quarter ending 2025-12-31 was $200.00, a 0.00% change year-over-year.
- INOVIO PHARMACEUTICALS, INC. debt securities, available-for-sale, realized gain for the quarter ending 2025-09-30 was $300.00, a 50.00% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. debt securities, available-for-sale, realized gain for fiscal 2025 was $1.00K, a 11.11% increase from fiscal 2024.
- INOVIO PHARMACEUTICALS, INC. debt securities, available-for-sale, realized gain for fiscal 2024 was $900.00, a 10.00% decline from fiscal 2023.
- INOVIO PHARMACEUTICALS, INC. debt securities, available-for-sale, realized gain for fiscal 2023 was $1.00K, a 95.24% decline from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. debt securities, available-for-sale, realized gain for fiscal 2022 was $21.00K, a 94.67% decline from fiscal 2021.
| Period end | Debt Securities, Available-for-sale, Realized Gain 3 month | Debt Securities, Available-for-sale, Realized Gain 6 month | Debt Securities, Available-for-sale, Realized Gain 9 month | Debt Securities, Available-for-sale, Realized Gain 12 month |
|---|---|---|---|---|
| 2026-06-30 | $200.00 10-Q · filed 2026-08-12 | $400.00 10-Q · filed 2026-08-12 | $600.00 derived: sum of 3 quarters · filed 2026-08-12 | $900.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $200.00 10-Q · filed 2026-05-13 | $400.00 derived: sum of 2 quarters · filed 2026-05-13 | $700.00 derived: sum of 3 quarters · filed 2026-05-13 | $1.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $200.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $500.00 derived: sum of 2 quarters · filed 2026-03-12 | $800.00 derived: sum of 3 quarters · filed 2026-08-12 | $1.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $300.00 10-Q · filed 2025-11-10 | $600.00 derived: sum of 2 quarters · filed 2026-08-12 | $800.00 10-Q · filed 2025-11-10 | $1.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $300.00 10-Q · filed 2026-08-12 | $500.00 10-Q · filed 2026-08-12 | $700.00 derived: sum of 3 quarters · filed 2026-08-12 | $900.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $200.00 10-Q · filed 2026-05-13 | $400.00 derived: sum of 2 quarters · filed 2026-05-13 | $600.00 derived: sum of 3 quarters · filed 2026-05-13 | $900.00 derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $200.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $400.00 derived: sum of 2 quarters · filed 2026-03-12 | $700.00 derived: sum of 3 quarters · filed 2026-03-12 | $900.00 10-K · filed 2026-03-12 |
| 2024-09-30 | $200.00 10-Q · filed 2025-11-10 | $500.00 derived: sum of 2 quarters · filed 2025-11-10 | $700.00 10-Q · filed 2025-11-10 | $900.00 derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $300.00 10-Q · filed 2025-08-12 | $500.00 10-Q · filed 2025-08-12 | $700.00 derived: sum of 3 quarters · filed 2025-08-12 | $1.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $200.00 10-Q · filed 2025-05-13 | $400.00 derived: sum of 2 quarters · filed 2025-05-13 | $700.00 derived: sum of 3 quarters · filed 2025-05-13 | $900.00 derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $200.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $500.00 derived: sum of 2 quarters · filed 2025-03-18 | $700.00 derived: sum of 3 quarters · filed 2025-03-18 | $1.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | $300.00 10-Q · filed 2024-11-14 | $500.00 derived: sum of 2 quarters · filed 2024-11-14 | $800.00 10-Q · filed 2024-11-14 | $800.00 derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $200.00 10-Q · filed 2024-08-08 | $500.00 10-Q · filed 2024-08-08 | $500.00 derived: sum of 3 quarters · filed 2024-08-08 | $1.50K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $300.00 10-Q · filed 2024-05-13 | $300.00 derived: sum of 2 quarters · filed 2024-05-13 | $1.30K derived: sum of 3 quarters · filed 2024-05-13 | $2.30K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $1.00K derived: sum of 2 quarters · filed 2024-03-06 | $2.00K derived: sum of 3 quarters · filed 2024-03-06 | $21.00K 10-K · filed 2024-03-06 |
| 2022-09-30 | $1.00K 10-Q · filed 2023-11-09 | $2.00K derived: sum of 2 quarters · filed 2023-11-09 | $21.00K 10-Q · filed 2023-11-09 | $36.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.00K 10-Q · filed 2023-08-09 | $21.00K 10-Q · filed 2023-08-09 | $35.00K derived: sum of 3 quarters · filed 2023-08-09 | $57.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $20.00K 10-Q · filed 2023-05-10 | $34.00K derived: sum of 2 quarters · filed 2023-05-10 | $56.00K derived: sum of 3 quarters · filed 2023-05-10 | $414.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $36.00K derived: sum of 2 quarters · filed 2023-03-01 | $394.00K derived: sum of 3 quarters · filed 2023-03-01 | $394.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $22.00K 10-Q · filed 2022-11-08 | $380.00K derived: sum of 2 quarters · filed 2022-11-08 | $380.00K 10-Q · filed 2022-11-08 | $383.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $358.00K 10-Q · filed 2022-08-09 | $358.00K 10-Q · filed 2022-08-09 | $361.00K derived: sum of 3 quarters · filed 2022-08-09 | $466.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | $3.00K derived: sum of 2 quarters · filed 2022-05-10 | $108.00K derived: sum of 3 quarters · filed 2022-05-10 | $693.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $108.00K derived: sum of 2 quarters · filed 2022-03-01 | $693.00K derived: sum of 3 quarters · filed 2022-03-01 | $744.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $105.00K 10-Q · filed 2021-11-09 | $690.00K derived: sum of 2 quarters · filed 2021-11-09 | $741.00K 10-Q · filed 2021-11-09 | $1.00M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $585.00K 10-Q · filed 2021-08-09 | $635.00K 10-Q · filed 2021-08-09 | $899.00K derived: sum of 3 quarters · filed 2021-08-09 | $1.05M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $50.00K 10-Q · filed 2021-05-10 | $314.00K derived: sum of 2 quarters · filed 2021-05-10 | $469.00K derived: sum of 3 quarters · filed 2021-05-10 | $626.00K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $419.00K derived: sum of 2 quarters · filed 2021-03-01 | $576.00K derived: sum of 3 quarters · filed 2021-03-01 | $594.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $155.00K 10-Q · filed 2020-11-09 | $312.00K derived: sum of 2 quarters · filed 2020-11-09 | $330.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $157.00K 10-Q · filed 2020-08-10 | $175.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $18.00K 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $20.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |